Phase 2 trial of linifanib (ABT-869) in patients with advanced non-small cell lung cancer

• Main Authors: Tan, E.-H., Goss, G.D., Salgia, R., Besse, B., Gandara, D.R., Hanna, N.H., Yang, J.C.-H., Thertulien, R., Wertheim, M., Mazieres, J., Hensing, T., Lee, C., Gupta, N., Pradhan, R., Qian, J., Qin, Q., Scappaticci, F.A., Ricker, J.L., Carlson, D.M., Soo, R.A.
• Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
• Format: Review
• Published: 2014
• Subjects: Angiogenesis; Linifanib (ABT-869); NSCLC; PDGFR; VEGFR
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/117354
• Institution: National University of Singapore

10.1097/JTO.0b013e318220c93e